Patient Death Halts Carmat Trial

Carmat’s goal of obtaining a CE mark Certification for its artificial heart by the beginning of 2018 already looked ambitious; now it looks impossible. The French regulator ANSM has ordered the group to suspend implants of the device in its pivotal European trial following the death of the first patient in the study.

While regulatory caution is of course to be applauded, this may be a little harsh on the French company. The patients the heart is designed to treat are gravely ill, with a life expectancy of around two weeks. In this case, implantation of Carmat’s product allowed the patient to live at least a month.

The company’s shares initially fell by 29%, but have partly recovered and are now trading down 13% on yesterday’s close.

                                                                              -   03 Dec 2016

ISO 9001:2015

The purpose of ISO 9001:2015 is to facilitate international trade by providing a single standard that is recognized and respected globally.

Read More

ISO 14001:2015

The ISO 14001 standard specifies a process for the control and the continuous improvement of an organization’s environmental performance.

Read More

ISO 18001:2007

18001 Standards are British Standards but considering its benefit, impact & Popularity. Health & Safety of employee is one of the most important aspects of any organization.

Read More